T he left atrial appendage (LAA) has been considered for years as a less relevant part of the left atrium. During the years, its function and role have been extensively studied.The LAA is recognized as the major source (95%) of cardiac emboli in patients with nonvalvular atrial fibrillation (AF). In addition, the LAA has been shown to have important roles in atrial natriuretic peptide secretion and as an underreported trigger site of AF. [1][2][3][4][5][6][7] From an anatomic point of view, the LAA has a trabecular tubular shape with variable morphologies and derives from the embryonic left atrium as an outgrowth of the pulmonary veins.
6,7
See Article by Panikker et alCatheter ablation of AF is a valid therapeutic option for the treatment of AF and has been shown to be superior to antiarrhythmic drugs for maintaining sinus rhythm. 8,9 Pulmonary vein (PV) isolation is the primary target for ablation. 9 Procedural success rates vary depending on the experience of the operator and on the subtype of atrial fibrillation: higher in paroxysmal and lower in persistent and longstanding, persistent AF. Many patients continue to experience AF recurrences, despite permanent PV isolation. In such cases, several authors have identified additional targets for ablation outside the pulmonary veins, the so called non-PV triggers.
10-12The most common non-PV trigger sites are the superior vena cava, the coronary sinus, the atrial septum, the posterior wall, the ligament of Marshall, and, more recently emphasized, the LAA. [12][13][14][15][16][17][18][19] It is important to consider that the Cox-Maze III surgery data have demonstrated a 90% success rate at maintaining sinus rhythm and a low incidence of thromboembolic events, and this procedure excludes or excises the LAA. 20 The surgical data and the experience and lessons learned by burning guided our group to consider the LAA as a target for ablation.In our first series in 2010, we showed that LAA electric isolation rather than focal LAA ablation was the best strategy to maintain sinus rhythm at follow-up in a series of patients that failed previous procedures and showed sustained LAA firing. 12 We also showed that after electric isolation of the LAA, in ≈50% of cases, lifelong anticoagulation is recommended to reduce the risk of thromboembolic complications.12 To eliminate the need for lifelong anticoagulation, LAA closure devices could potentially be used. It is also important to note that based on the current recommendations, 9 discontinuation of oral anticoagulation (OAC) after successful ablation is allowed only in patients with a CHA 2 DS 2 -VASc score <2 and that the majority of patients with nonparoxysmal AF that may require LAA electric isolation have a CHA 2 DS 2 -VASc score ≥2.In this issue of the Journal, Panikker et al 21 sought to assess the feasibility, safety, and efficacy of concomitant LAA electric isolation and LAA occlusion with the Watchman closure device in 22 patients undergoing long-standing, persistent AF ablation. Outcomes were compared with a balanced...